Thema
Journal Article
22
O3J8G9O825
22
Ritonavir
22
Dissolution
4
Solubility
4
2494G1JF75
3
Amorphous solid dispersion
3
COVID-19
3
HIV Protease Inhibitors
3
Indomethacin
3
Lipids
3
Lopinavir
3
Research Support, Non-U.S. Gov't
3
Tablets
3
XXE1CET956
3
Antiviral Agents
2
Digestion
2
Dissolution rate
2
Drug Combinations
2
Hot-melt extrusion
2
Lipid based formulation
2
Liquid-liquid phase separation
2
Microfluidization
2
Nanosuspension
2
Oral absorption
2
Oral drug delivery
2
Pharmaceutical Preparations
2
Polymers
2
Polyvinyls
2
Pyrrolidines
2
Ritonavir (PubChem CID: 392622)
2
Surface-Active Agents
2
Suspensions
2
nirmatrelvir and ritonavir drug combination
2
059QF0KO0R
1
1,2-Didecanoyl-sn-glycero-3-phosphocholine (10:0 PC)
1
1,2-Didecanoyl-sn-glycero-3-phosphocholine (10:0 PC) (PubChem CID: 166886)
1
1,2-Dioctanoyl-sn-glycero-3-phosphocholine (8:0 PC)
1
1,2-Dioctanoyl-sn-glycero-3-phosphocholine (8:0 PC) (PubChem CID: 24779244)
1
1,2-dioctanoyl-sn-glycero-3-phosphocholine
1
1,6-Diphenyl-1,3,5-hexatriene (PubChem CID: 5376733)
1
1N3CZ14C5O
1
32K497ZK2U
1
33CM23913M
1
368GB5141J
1
3NXW29V3WO
1
3WJQ0SDW1A
1
5E090O0G3Z
1
6W9PS8B71J
1
7631-86-9
1
mehr ...